☆ 3.8 Article

The Fatty Liver, Cirrhosis, and Liver Cancer Study (TENDENCY): Protocol for a Multicenter Case-Control Study

JMIR RESEARCH PROTOCOLS (2023)

Related references

Note: Only part of the references are listed.

Editorial Material Oncology

Editorial: Altered Expression of Proteins in Cancer: Function and Potential Therapeutic Targets

Joao Pessoa et al.

FRONTIERS IN ONCOLOGY (2022)

Add to Collection

Article Biochemistry & Molecular Biology

Exploratory Study Using Urinary Volatile Organic Compounds for the Detection of Hepatocellular Carcinoma

Ayman S. Bannaga et al.

Summary: This study investigated the pattern and composition of urinary volatile organic compounds (VOCs) in HCC patients, showing that GC-IMS and GC-TOF-MS analysis can effectively identify HCC cases. The findings enhanced understanding of the pathogenesis of HCC.

MOLECULES (2021)

Add to Collection

Article Gastroenterology & Hepatology

Role of methylated septin 9 as an adjunct diagnostic and prognostic biomarker in hepatocellular carcinoma

Ayman S. Bannaga et al.

Summary: The study found that mSEPT9 has high sensitivity and specificity in patients with hepatocellular carcinoma, serving as a potential diagnostic and prognostic biomarker. Even after adjusting for age, mSEPT9 remained associated with liver function, liver fibrosis and inflammatory surrogate markers.

HPB (2021)

Add to Collection

Article Oncology

Pathophysiological Implications of Urinary Peptides in Hepatocellular Carcinoma

Ayman Bannaga et al.

Summary: Capillary electrophoresis mass spectrometry was used in this study to identify 31 urinary peptides significantly associated with hepatocellular carcinoma diagnosis and prognosis. These peptides were found to predict proteases involved in the development of the cancer, offering a potential noninvasive tool for diagnosis and prognosis. Immunohistochemistry verification of the identified proteases in liver tissues further supported their potential roles in liver fibrosis and cancer formation.

CANCERS (2021)

Add to Collection

Review Biochemistry & Molecular Biology

Liver Impairment-The Potential Application of Volatile Organic Compounds in Hepatology

Georgios Stavropoulos et al.

Summary: This study reviews the research on volatile organic compounds in liver diseases and identifies compounds that could be used as biomarkers. The literature search found articles related to VOCs in breath, bile, urine, and feces. Suggestions on how VOC analysis could be applied in clinical practice are provided.

METABOLITES (2021)

Add to Collection

Article Medicine, General & Internal

Performance of the Enhanced Liver Fibrosis Test to Estimate Advanced Fibrosis Among Patients With Nonalcoholic Fatty Liver Disease

Zobair M. Younossi et al.

Summary: The enhanced liver fibrosis (ELF) test performs well in identifying NAFLD patients at increased risk of advanced fibrosis, and when combined with the fib-4 score, it can be reliably used in clinical practice to assess the presence of advanced fibrosis among patients with NAFLD.

JAMA NETWORK OPEN (2021)

Add to Collection

Review Pathology

Urine as a biological modality for colorectal cancer detection

Subashini Chandrapalan et al.

EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2020)

Add to Collection

Review Cell Biology

Biomarkers in Hepatocellular Carcinoma: Diagnosis, Prognosis and Treatment Response Assessment

Federico Pinero et al.

CELLS (2020)

Add to Collection

Review Oncology

New Blood Biomarkers for the Diagnosis of AFP-Negative Hepatocellular Carcinoma

Ting Wang et al.

FRONTIERS IN ONCOLOGY (2020)

Add to Collection

Article Oncology

Plasma levels of methylated septin 9 are capable of detecting hepatocellular carcinoma and hepatic cirrhosis

Na He et al.

MOLECULAR MEDICINE REPORTS (2020)

Add to Collection

Article Biotechnology & Applied Microbiology

SEPT9 Gene Methylation as a Noninvasive Marker for Hepatocellular Carcinoma

Baoliang Li et al.

DISEASE MARKERS (2020)

Add to Collection

Article Gastroenterology & Hepatology

AASLD guidelines for the treatment of hepatocellular carcinoma

Julie K. Heimbach et al.

HEPATOLOGY (2018)

Add to Collection

Article Gastroenterology & Hepatology

Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases

Jorge A. Marrero et al.

HEPATOLOGY (2018)

Add to Collection

Article Gastroenterology & Hepatology

EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma

Peter R. Galle et al.

JOURNAL OF HEPATOLOGY (2018)

Add to Collection

Article Medicine, General & Internal

Mortality assessment of patients with hepatocellular carcinoma according to underlying disease and treatment modalities

Pegah Golabi et al.

MEDICINE (2017)

Add to Collection

Article Gastroenterology & Hepatology

DNA methylation-based prognosis and epidrivers in hepatocellular carcinoma

Augusto Villanueva et al.

HEPATOLOGY (2015)

Add to Collection

Article Medical Laboratory Technology

DNA methylation biomarkers for blood-based colorectal cancer screening

Catherine Lofton-Day et al.

CLINICAL CHEMISTRY (2008)

Add to Collection

Article Gastroenterology & Hepatology

Hepatocellular carcinoma in cirrhosis: Incidence and risk factors

G Fattovich et al.

GASTROENTEROLOGY (2004)

Add to Collection

Article Biochemical Research Methods

Determination of peptides and proteins in human urine with capillary electrophoresis-mass spectrometry, a suitable tool for the establishment of new diagnostic markers

S Wittke et al.

JOURNAL OF CHROMATOGRAPHY A (2003)

Add to Collection

© Peeref 2019-2024. All rights reserved.